A detailed history of Brightworth transactions in Eli Lilly & CO stock. As of the latest transaction made, Brightworth holds 2,145 shares of LLY stock, worth $1.74 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,145
Previous 2,108 1.76%
Holding current value
$1.74 Million
Previous $684,000 1.46%
% of portfolio
0.07%
Previous 0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 28, 2022

BUY
$296.48 - $337.87 $10,969 - $12,501
37 Added 1.76%
2,145 $694,000
Q2 2022

Jul 25, 2022

BUY
$278.73 - $327.27 $278 - $327
1 Added 0.05%
2,108 $684,000
Q1 2022

Apr 29, 2022

BUY
$234.69 - $291.66 $494,491 - $614,527
2,107 New
2,107 $604,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $773B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Brightworth Portfolio

Follow Brightworth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brightworth, based on Form 13F filings with the SEC.

News

Stay updated on Brightworth with notifications on news.